Why the study?
SLE is an independent risk factor for CVD, but it remained unclear which among QRISK2, QRISK3, FRS, mFRS, and SLECRE best predicts CVD.
Which cardiovascular risk prediction tool best predicts 10-year CVD risk in patients with systemic lupus erythematosus?
Which cardiovascular risk prediction tool best predicts 10-year CVD risk in patients with systemic lupus erythematosus?
Answers are grounded in this paper and cite their sources.
The modified Framingham Risk Score (mFRS) is a practical and superior tool for predicting 10-year cardiovascular disease risk in patients with systemic lupus erythematosus compared to FRS and QRISK tools.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Stevenson et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: